Skip to main navigation Skip to search Skip to main content

The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis

  • Aaron Korkegian
  • , Theresa O'Malley
  • , Yi Xia
  • , Yasheen Zhou
  • , David S. Carter
  • , Bjorn Sunde
  • , Lindsay Flint
  • , Dean Thompson
  • , Thomas R. Ioerger
  • , Jim Sacchettini
  • , M. R.K. Alley
  • , Tanya Parish
  • Infectious Disease Research Institute
  • Pfizer
  • Texas A&M University

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Abstract

We identified a series of novel 7-phenyl benzoxaborole compounds with activity against Mycobacterium tuberculosis. Compounds had a range of activity with inhibitory concentrations (IC90) as low as 5.1 μM and no cytotoxicity against eukaryotic cells (IC50 > 50 μM). Compounds were active against intracellular mycobacteria cultured in THP-1 macrophages. We isolated and characterized resistant mutants with mutations in NADH dehydrogenase (Ndh) or the regulatory protein Mce3R. Mutations suggest that Ndh may be the target of this series.

Original languageEnglish
Pages (from-to)96-98
Number of pages3
JournalTuberculosis
Volume108
Early online date7 Nov 2017
DOIs
Publication statusPublished - 1 Jan 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis'. Together they form a unique fingerprint.

Cite this